RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.23M | -12.10M | -15.88M | -9.15M | -9.82M |
| Total Depreciation and Amortization | 929.00K | 999.00K | 834.00K | 851.00K | 854.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.66M | 7.04M | 6.15M | 6.60M | 6.03M |
| Change in Net Operating Assets | 52.85M | -5.48M | -1.99M | 584.00K | 1.75M |
| Cash from Operations | 45.22M | -9.54M | -10.89M | -1.12M | -1.19M |
| Capital Expenditure | -1.17M | -1.96M | -759.00K | -1.14M | -581.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.12M | 6.61M | 9.61M | -8.48M | -8.42M |
| Cash from Investing | 7.95M | 4.65M | 8.85M | -9.61M | -9.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.00K | -7.00K | -7.00K | 9.00K | -19.00K |
| Issuance of Common Stock | 227.00K | 669.00K | 144.00K | 1.06M | 131.00K |
| Repurchase of Common Stock | -25.00K | 0.00 | -473.00K | -2.00K | -642.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 195.00K | 662.00K | -336.00K | 1.06M | -530.00K |
| Foreign Exchange rate Adjustments | 8.00K | 3.00K | 3.00K | -15.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -1.00K | -- |
| Net Change in Cash | 53.37M | -4.22M | -2.38M | -9.68M | -10.72M |